European Commission/EMA meeting with stakeholders on Translarna (ataluren)

Date

, -

Location

Online

Event summary

EMA and the European Commission are organising a meeting with patients, healthcare professionals and their organisations.

The meeting aims to provide an overview of the evaluation process, the evidence considered, the stakeholder involvement and the scientific grounds for EMA's recommendation on Translarna.

There will also be an opportunity for patients, their caregivers and healthcare professionals to raise questions.

Registration

Registration by invitation only.

Documents

Share this page